Author
Listed:
- Mercy Adusei Boatemaa
(Department of Electrical and Electronics Engineering, University of Skills Training and Entrepreneurial Development, Faculty of Engineering and Technology, Kumasi,)
Abstract
A novel nanocomposite comprising pectin, zeolite, and zinc oxide (ZnO) nanoparticles (NPs) was hypothesised to enhance antibacterial activity through synergistic effects. Consequently, the material was investigated as a green antibacterial agent for biomedical applications. Pectin was extracted from green apples using ethanol precipitation and dried at 50°C. The nanocomposite was prepared by mixing 1% (w/v) pectin, 2% (w/v) zeolite, and 0.5% (w/v) ZnO nanoparticles in water, followed by stirring for 2 hours at room temperature. For antibacterial testing, 100 µL of a 10^6 CFU/mL bacterial suspension was spread on Mueller-Hinton agar. Composite discs (6 mm diameter, 20 mg) were placed on the plates. After 24 hours of incubation at 37°C, inhibition zones were measured. Minimum inhibitory concentrations were determined by broth microdilution (10–200 µg/mL) in 96-well plates. FTIR analysis confirmed the presence of functional group interactions within the materials. The pectin-zeolite-ZnO nanocomposite had strong antibacterial activity against both bacteria. For Staphylococcus aureus, the nanocomposite produced an inhibition zone of 18 ± 0.5 mm and for Escherichia coli, 16 ± 0.6 mm. These values were significantly greater than those observed for the pectin (9.3 ± 0.3 mm), zeolite (10.1 ± 0.4 mm), or ZnO nanoparticles alone (13 ± 0.5 mm). The minimum inhibitory concentration (MIC) for the nanocomposite was 40 µg/mL against S. aureus and 50 µg/mL against E. coli. This increase in antibacterial efficacy results from the synergy among zeolite, pectin, and ZnO nanoparticles, which enhances bacterial cell disruption and inhibition. The developed nanocomposite is a promising antibacterial agent. Its strong antibacterial activity suggests potential use in biomedical applications such as wound dressings, implant coatings, or antibacterial surfaces, where effective inhibition of bacterial growth is essential. These results highlight the nanocomposite's translational potential for preventing infections and supporting the development of safe biomedical devices.
Suggested Citation
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bjf:journl:v:11:y:2026:i:6:p:2187-2200. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Dr. Renu Malsaria (email available below). General contact details of provider: https://rsisinternational.org/journals/ijrias/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.